Loading stock data...

“Professor Maestretti Presents Clinical Results on Sycamore Device at 16th Journées Thérapeutiques Interventionnelles Vertébrales et Ostéo-Articulaires Meeting, Hosted by SAFE GROUP”

16th Journées Thérapeutiques Interventionnelles Vertébrales et Ostéo-Articulaires: Presentation of Professor Maestretti’s Clinical Results on the Sycamore Device

January 7, 2025 – Fleurieux-sur-l’Arbresle, France – 6pm

Safe announces that Professor Gianluca Maestretti, Head of Orthopaedics at the Freiburg Hospital, will present his clinical results on the Sycamore device at the 16th Journées Thérapeutiques Interventionnelles Vertébrales et Ostéo-Articulaires, to be held in Nice on January 24, 2025.

About Professor Maestretti’s Presentation

Professor Maestretti is a renowned expert in orthopaedic surgery with extensive experience in the treatment of spinal pathologies. His presentation will focus on his clinical observations and results obtained using the Sycamore device for the minimally invasive treatment of vertebral fractures. This cutting-edge technology has been developed by Safe Orthopaedics, a pioneer in ready-to-use technologies for spine pathologies.

The Sycamore Device: A Breakthrough in Minimally Invasive Spinal Care

The Sycamore device is an innovative solution designed to address the growing demand for minimally invasive treatments of vertebral fractures. This technology enables interventional radiologists to effectively treat vertebral fractures while minimizing risks and reducing recovery times. The introduction of the Sycamore device into clinical practice marks a significant step forward for Safe Orthopaedics, solidifying its position as a key player in the innovation of therapeutic solutions for spinal pathologies.

Presentation Highlights

  • Minimally Invasive Treatment: Professor Maestretti’s presentation will highlight the benefits of minimally invasive treatment using the Sycamore device.
  • Clinical Results: The presentation will showcase Professor Maestretti’s clinical results and observations obtained using the Sycamore device.
  • Panel Discussion: A panel discussion with experts in interventional radiology will follow, focusing on the growing impact of this technology in spinal care.

The Growing Importance of Interventional Radiology

Interventional radiology is a rapidly evolving field that has gained significant recognition in recent years. The Sycamore device’s integration into clinical practice marks a strategic step forward for Safe Orthopaedics, solidifying its position as a leader in this growing specialty.

About Safe Group

Safe Group is a French medical technology group composed of two subsidiaries:

  • Safe Orthopaedics: Develops and manufactures ready-to-use technologies for spine pathologies.
  • Safe Medical: Produces implantable medical devices and ready-to-use instruments.

The group employs approximately 100 people and has an innovation center, production sites in France and Tunisia, as well as subsidiaries in the United Kingdom, Germany, and the United States.

About Safe Orthopaedics

Safe Orthopaedics develops and manufactures kits combining sterile implants and ready-to-use instruments. These technologies are part of a minimally invasive approach aimed at reducing risks of contamination and infection, benefiting patients while positively impacting hospitalization times and costs. The company’s SteriSpineTM kits are CE marked and FDA approved.

About Safe Medical

Safe Medical produces implantable medical devices and ready-to-use instruments. It has an innovation center and two production sites in France and Tunisia, offering numerous industrial services: industrialization, machining, finishing, and sterile packaging.

Contact Information

For more information about the Sycamore device and Safe Group’s subsidiaries, please visit:

To learn more about the 16th Journées Thérapeutiques Interventionnelles Vertébrales et Ostéo-Articulaires, visit: